Weatherford International plc financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Weatherford International plc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	5,699	5,744	4,954	4,954	3,685	3,645	4,331	5,135	5,513	4,918
Cost of revenue	2,142
Gross profit	810	1,230		1,101
Research and development	158	139	136		97	85	90	112	123	108
General and administrative	130	130	118
Operating income	-2,170	-2,084	-1,182		-1,486	116	412	820	938	756
Other non-operating income	7	-59	-26		-62	-29	-95	-129	-78	-70
Pre-tax income	-2,656	-2,757	3,819		-1,814	-343	138	506	739	554
Income tax	137	34	135		85	86	87	57	189	97
Net income to minority interests	20	20	23		22	21	25	32	44	26
Net income	-2,813	-2,811	3,661	3,661	-1,921	-450	26	417	506	431
EBITDA	-1,369	-1,528	-735		-983	556	761	1,147	1,281	1,023
EPS, basic	-2.84	-2.82	3.65	3.65	-27.44	-6.43	0.37	5.79	6.93	5.96
EPS, diluted	-2.84	-2.82	3.65	3.65	-27.44	-6.43	0.36	5.66	6.75	5.93
Shares, basic (weighted)	990	997	1,004		70	70	70.5	71.9	73	72.2
Shares, diluted (weighted)	990	997	1,004	1,004	70	70	71.6	73.6	74.9	72.6
Dividend per share									0.50	1.00

Balance sheet

	FY2017	FY2018	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	613	602	754	618	1,118	951	910	958	916	987
Receivables	1,103	1,051		1,156	826	825	989	1,216	1,261	1,234
Inventory	1,234	1,025		972	717	670	689	788	880	836
Other current assets	569	693		440	349	303	253	278	286	260
Total current assets	3,878	3,450		3,453	3,177	2,911	3,043	3,345	3,402	3,372
Property, plant and equipment	2,708	2,086		2,122	1,236	996	918	957	1,061	1,124
Lease right-of-use assets				256	138	113	115	138	124	128
Goodwill	2,727	713	0	239	0
Intangible assets	213	213		1,114	810	657	506	370	325	285
Other non-current assets	434	139		109	73	97	138	258	247	288
Total assets	9,747	6,601		7,293	5,434	4,774	4,720	5,068	5,159	5,197
Accounts payable	856	732		585	325	380	460	679	792	650
Accrued liabilities	308	249		270	297	343	367	387	302	285
Deferred revenue							54	58	51	48
Short-term debt	148	383		13	13	12	45	168	17	30
Total current liabilities	2,230	2,300		1,672	1,362	1,332	1,470	1,866	1,696	1,537
Long-term debt	7,541	7,605		2,151	2,601	2,416	2,203	1,715	1,617	1,455
Lease liabilities				213	177	128	117	131	110	109
Other non-current liabilities	547	362		341	357	402	128	152	179	158
Total liabilities	10,318	10,267		4,377	4,497	4,278	4,169	4,146	3,876	3,501
Total debt	7,678	7,662		2,161	2,553	2,372	2,272	1,830	1,586	1,415
Paid-in capital	6,655	6,711		2,897	2,897	2,904	2,928	2,906	2,921	2,815
Retained earnings	-5,763	-8,671		-26	-1,947	-2,397	-2,371	-1,954	-1,486	-1,129
Other comprehensive income	-1,519	-1,746	0	9	-43	-35	-22	-28	-150	13
Shareholders' equity	-626	-3,705		2,880	907	472	535	924	1,285	1,699
Minority interests	55	39		36	30	24	16	-2	-2	-3
Total equity	-571	-3,666	2,931	2,916	937	496	551	922	1,283	1,696
Total liabilities and equity	9,747	6,601		7,293	5,434	4,774	4,720	5,068	5,159	5,197
Shares outstanding	993	1,002		70	70	70	71	72.1	72.1	71.6

Cash flow statement

	FY2017	FY2018	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-2,793	-2,791	3,684	3,661	-1,899	-429	51	449	550	457
Depreciation and amortization	801	556	447		503	440	349	327	343	267
Stock-based compensation	70	47	46		0	25	25	35	45	38
Deferred income tax	-25	-79	25		-5	-10	4	-86	8	-14
Change in receivables	-29	-70	-135		378	-6	-193	-221	-31	75
Change in inventory	-37	86	-215		64	-18	-56	-114	-112	24
Change in payables					-250	56	84	231	97	-131
Cash from operations	-388	-242	-747		210	322	349	832	792	676
Capital expenditures	-225	-186	-250		-154	-85	-132	-209	-299	-226
Acquisitions	-7	4	0		0		0	-4	-51	0
Purchases of investments						0	0	-110	-50	-117
Sales and maturities of investments						0	0	53	40	115
Cash from investing	-62	122	149		-75	-83	-54	-289	-293	-145
Debt issued	250	586	1,600		453	2,073	0	0	0	1,200
Stock issued	0	0
Share buybacks							0	0	-99	-101
Dividends paid							0	0	-36	-72
Cash from financing	20	168	749		348	-403	-248	-514	-511	-474
Exchange rate effect	6	-59	1		2	-8	-48	-78	-76	10
Net change in cash	-424	-11	152		485	-172	-1	-49	-88	67
Free cash flow	-613	-428	-997		56	237	217	623	493	450
Interest paid	538	584	272		232	269	220	181	153	125
Income taxes paid	87	99	89		79	62	86	132	168	157

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $85.08 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	12.7%	Operating income / revenue.
EBITDA margin	18.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	9.4%	Pre-tax income / revenue.
Net margin	7.7%	Net income / revenue.
FCF margin	11.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	15.0%	Cash from operations / revenue.
Effective tax rate	15.7%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	20.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	7.2%	Net income / average total assets.
Return on invested capital (ROIC)	23.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	1.9%	Research and development expense / revenue.
Stock-based pay / revenue	0.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	4.0%	Capital expenditures / revenue.
D&A / revenue	5.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-10.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	4.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	5.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-19.4%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	22.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	-20.1%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	10.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	-14.8%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	155.0%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	-12.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	154.4%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-14.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	24.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	26.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-8.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	27.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	51.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	100.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	32.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	47.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	13.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	0.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	3.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-0.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-3.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.34x	Current assets / current liabilities.
Quick ratio	1.57x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.78x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.83x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	29.0%	Total debt / total assets.
Liabilities / assets	64.9%	Total liabilities / total assets.
Net debt	$380.0M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.43x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$1.89B	Current assets - current liabilities.
Goodwill and intangibles / assets	5.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	$1.52B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.94x	Revenue / average total assets.
Fixed asset turnover	4.22x	Revenue / average property, plant and equipment.
Receivables turnover	4.33x	Revenue / average receivables.
Days sales outstanding	84 days	365 x average receivables / revenue.
FCF conversion	143.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	26.6%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.07	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$66.18	Revenue / diluted weighted shares.
FCF per share	$7.29	Free cash flow / diluted weighted shares.
Operating cash flow per share	$9.93	Cash from operations / diluted weighted shares.
Book value per share	$24.90	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$21.21	Tangible book value / shares outstanding.
Cash per share	$15.32	(Cash + short-term investments) / shares outstanding.
Payout ratio	20.8%	Dividends paid / net income, when net income is positive.
Dividends / FCF	14.4%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	7.6%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$6.10B	Share price x shares outstanding.
Enterprise value	$6.48B	Market cap + total debt - cash - short-term investments.
P/E	16.7x	Market cap / net income. Only when net income is positive.
P/S	1.28x	Market cap / revenue.
P/B	3.41x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	4.00x	Market cap / tangible book value, when positive.
P/FCF	11.6x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	8.51x	Market cap / cash from operations, when positive.
EV/Sales	1.36x	Enterprise value / revenue.
EV/EBIT	10.7x	Enterprise value / operating income, when both are positive.
EV/EBITDA	7.29x	Enterprise value / EBITDA, when both are positive.
EV/FCF	12.3x	Enterprise value / free cash flow, when both are positive.
FCF yield	8.6%	Free cash flow / market cap.
Earnings yield	6.0%	Net income / market cap (the inverse of P/E).
Dividend yield	1.2%	Dividends paid over the period / market cap.
Shareholder yield	1.9%	(Dividends paid + share buybacks) / market cap.
PEG	0.11x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Weatherford International plc's revenue in fiscal 2025?

Weatherford International plc reported revenue of $4.92B for fiscal 2025, 10.8% lower than the year before.

Was Weatherford International plc profitable in fiscal 2025?

Yes. Net income was $431.0M, a net margin of 8.8%.

How much free cash flow did Weatherford International plc generate in fiscal 2025?

Cash from operations of $676.0M minus capital expenditures of $226.0M left free cash flow of $450.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Weatherford International plc